EULAV Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-104,616	Closed	-$28.8M	–	148
2025 Q4	$28.8M	Hold	104,616	–	–	0.77%	42
2025 Q3	$27.4M	Sell	104,616 -33,000	-24%	-$8.02M	0.64%	53
2025 Q2	$30.1M	Hold	137,616	–	–	0.71%	41
2025 Q1	$30.8M	Sell	137,616 -7	-0%	-$1.93K	0.76%	42
2024 Q4	$45.1M	Hold	137,623	–	–	1.09%	29
2024 Q3	$41.3M	Buy	137,623 +2	+0%	+$612	1.01%	30
2024 Q2	$45.3M	Buy	137,621 +9,000	+7%	+$3.18M	1.23%	25
2024 Q1	$50.9M	Buy	128,621 +5	+0%	+$1.85K	1.4%	22
2023 Q4	$45.3M	Buy	128,616 +14,600	+13%	+$5.17M	1.4%	19
2023 Q3	$42.8M	Buy	114,016 +45,500	+66%	+$17.6M	1.56%	14
2023 Q2	$26.2M	Buy	68,516 +57,416	+517%	+$20.5M	0.98%	38
2023 Q1	$3.85M	Buy	+11,100	New	+$3.24M	0.15%	127